Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.
Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.
J Clin Hypertens (Greenwich). 2020 Mar;22(3):369-377. doi: 10.1111/jch.13763. Epub 2019 Dec 31.
Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines ("JSH 2019") continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.
与其他国际指南不同,但与早期的日本高血压学会(JSH)指南一致,2019 年 JSH 指南(“JSH 2019”)继续强调使用家庭血压设备进行非诊室血压(BP)测量的重要性。JSH 2019 的另一个独特特点是,它根据对更新证据的系统评价,提出了有关高血压管理的临床问题。JSH 2019 指出,诊室血压<140/90mmHg 的个体没有正常血压。最终的高血压诊断和治疗决策应基于诊室 BP 值和非诊室 BP 值。对于合并症的高血压成年人,诊室 BP 目标通常<130/80mmHg,家庭 BP 目标<125/75mmHg。JSH 2019 的建议不仅对日本高血压患者有价值,而且对亚洲高血压患者也有价值,亚洲高血压患者与日本高血压患者具有相同的特征,包括中风发生率高于心肌梗死和血压-血管事件关系更陡峭。